Status:
RECRUITING
Evaluation of Intermittent Triple Therapies in Real Life
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
The strategy of intermittent triple therapy for people living with HIV was validated in France following the randomized clinical trial QUATUOR. There is little data in real life, as shown in the meta-...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult subject (≥ 18 years old)
- Living with HIV monitored at the Trait d'Union/Infectious Diseases department in Strasbourg
- Having benefited from intermittent triple therapy between 01/01/2017 and 31/01/2024
- Exclusion criteria:
- Subject (and/or their legal representative if applicable) having expressed their opposition to the reuse of their data for scientific research purposes.
Exclusion
Key Trial Info
Start Date :
February 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 21 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06578702
Start Date
February 21 2024
End Date
February 21 2025
Last Update
August 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Le Trait d'Union - CHU de Strasbourg - France
Strasbourg, France, 67091